Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Cardiovascular Risk in Rheumatoid Arthritis: Pathogenesis, Screening & Prevention

Mary Beth Nierengarten  |  Issue: May 2019  |  May 18, 2019

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:Cardiovascular diseasecoronary artery calciumhyperlipidemiaMethotrexateTNF inhibitors

Related Articles

    REF Award Opens New Doors for Young Investigator

    May 1, 2007

    Do you know that old adage about the best-laid plans? If you ask Jon T. Giles, MD, about it, he’d agree that even the firmest plans change. “When I entered medical school at Vanderbilt University, I was convinced that I’d pursue subspecialty training in neurology,” recalls Dr. Giles. “My plan was to specialize in movement disorders.”

    Cardiovascular Risk in Tocilizumab Therapy for RA

    September 15, 2015

    Observation and research have confirmed that patients with rheumatoid arthritis (RA) are at greater risk of cardiovascular disease than their peers of similar age and gender, and that traditional risk factors and chronic inflammation associated with RA apparently play a significant role in that risk. However, predicting which patients with rheumatoid arthritis are at greater…

    Cardiovascular Disease Risk High in RA Patients

    June 1, 2010

    High incidence of metabolic disease and concurrent inflammation increases risk

    Old Drugs Can Learn New Tricks

    November 1, 2011

    Methotrexate and its mechanism of action

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences